Evidence-based interventions to restore or improve female fertility in women aged 30–42 years: a systematic review by etiology and evidence level - Report - MDSpire

Evidence-based interventions to restore or improve female fertility in women aged 30–42 years: a systematic review by etiology and evidence level

  • By

  • Maria Jimena Barroso Alverde

  • Sion Yu

  • Daniel Pascal Pontón

  • Denise Niza Benardete Harari

  • José Elias Tesone Lasman

  • June 9, 2026

  • 0 min

Share

Clinical Report: Evidence-Based Strategies for Enhancing Female Fertility

Overview

This systematic review synthesizes evidence on interventions to improve fertility in women aged 30-42, highlighting the effectiveness of various hormonal therapies, assisted reproductive technologies, and lifestyle modifications. Despite some promising findings, the certainty of live birth outcomes remains limited due to small sample sizes and methodological variability.

Background

Female infertility is a significant global health issue, affecting approximately one in six couples, particularly impacting women aged 30-42 years. The multifactorial nature of infertility, including conditions like PCOS and endometriosis, complicates diagnosis and treatment. Understanding effective interventions is crucial for improving reproductive outcomes and addressing the emotional and social burdens associated with infertility.

Data Highlights

No numerical data available for tabulation.

Key Findings

  • 21 studies met inclusion criteria, covering various interventions for enhancing fertility.
  • Myo-inositol and clomiphene with sildenafil showed improved pregnancy-related outcomes.
  • Structured stress management and specific ART strategies were associated with better outcomes.
  • Live-birth effects were supported by moderate-certainty evidence, limited by small sample sizes and heterogeneity.
  • Diagnostic approaches like serum progesterone profiling showed predictive value but no therapeutic effect.
  • Safety reporting was limited, with few studies addressing ovarian hyperstimulation syndrome and neonatal outcomes.

Clinical Implications

Clinicians should prioritize established hormonal and ART strategies while engaging in shared decision-making with patients, acknowledging the existing evidence gaps. Future interventions should focus on live birth outcomes and standardized reporting of safety data.

Conclusion

While several interventions show promise in improving pregnancy outcomes for women aged 30-42, the overall certainty regarding live birth and safety remains limited, necessitating further research.

Related Resources & Content

  1. Frontiers in Oncology, 2026 -- Influencing factors of fertility concerns in cancer patients of childbearing age: a systematic review and meta-analysis
  2. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Preconception and Ongoing Lifestyle Modifications in Overweight or Obese Women with PCOS Undergoing Fertility Treatment—A Randomized Controlled Trial
  3. Frontiers in Reproductive Health, 2026 -- Clinical challenges and therapeutic strategies in women with endometriosis, deep infiltrating endometriosis, and/or adenomyosis undergoing assisted reproductive technologies: a narrative review
  4. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Effects of Negative Pregnancy Experiences in the First IVF Cycle on Future Pregnancy Results
  5. American Society for Reproductive Medicine, 2024 -- The use of preimplantation genetic testing for aneuploidy: a committee opinion
  6. ESHRE Ovarian Stimulation Guideline 2026
  7. WHO Global Infertility Guideline 2025
  8. The use of preimplantation genetic testing for aneuploidy: a committee opinion (2024) | American Society for Reproductive Medicine | ASRM
  9. Evidence-based guideline: Premature Ovarian Insufficiency - PubMed

Original Source(s)

Related Content